;

Statistics for AC Immune SA (id:6740 ACIU)

Valuation metrics

Market cap

290.89M

Enterprise value

156.51M

Trailing P/E (ttm)

-4.19

Forward P/E

-11.76

PEG ratio

-11.76

Price/Sales (ttm)

7.10

Price/Book (mrq)

2.25

Enterprise Value/Revenue

3.39

Enterprise Value/EBITDA

-3.88

Overview

Shares outstanding

98.94M

Float

40.73M

Shares short

1.02M

% Held by insiders

3.00%

% Held by institutions

3.00%

Average volume (10 days)

141.65K

Average volume (90 days)

Price summary

52-Week low

2.25

52-Week high

5.14

52-Week change

-76.87%

Beta

1.28

50-Day moving average

3.16

200-Day moving average

3.34

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31, 2023

Most recent quarter (mrq)

September 30, 2024

Profitability

Profit margin

-97.29%

Operating margin

28.52%

Operational effectiveness

Return on assets

-12.04%

Return on equity

-31.16%

Income statement

Revenue (ttm)

3.00

Revenue per share (ttm)

3.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-40,055,396.00

Net income to common (ttm)

-54,233,000.00

Diluted EPS (ttm)

3.00

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

176.87M

Total cash per share (mrq)

1.58

Total debt (mrq)

3.08M

Total Debt/Equity (mrq)

2.37

Current ratio (mrq)

185.80%

Book value per share (mrq)

1.30

Cash flow

Cash flow statement

-61,874,000.00

Levered free cash flow (LFCF)

-54,233,000.00